KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Other Non Operating Income: 2020-2023

Historic Other Non Operating Income for AbCellera Biologics (ABCL) over the last 4 years, with Dec 2023 value amounting to $3.4 million.

  • AbCellera Biologics' Other Non Operating Income rose 101.55% to $3.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $14.4 million, marking a year-over-year increase of 36.19%. This contributed to the annual value of $62.3 million for FY2024, which is 339.97% up from last year.
  • AbCellera Biologics' Other Non Operating Income amounted to $3.4 million in Q4 2023, which was up 19.38% from $2.8 million recorded in Q3 2023.
  • AbCellera Biologics' 5-year Other Non Operating Income high stood at $7.8 million for Q2 2020, and its period low was -$2.3 million during Q3 2020.
  • In the last 3 years, AbCellera Biologics' Other Non Operating Income had a median value of $3.5 million in 2023 and averaged $3.5 million.
  • As far as peak fluctuations go, AbCellera Biologics' Other Non Operating Income skyrocketed by 380.02% in 2021, and later crashed by 68.47% in 2022.
  • AbCellera Biologics' Other Non Operating Income (Quarterly) stood at -$1.9 million in 2020, then soared by 380.02% to $5.3 million in 2021, then tumbled by 68.47% to $1.7 million in 2022, then skyrocketed by 101.55% to $3.4 million in 2023.
  • Its Other Non Operating Income was $3.4 million in Q4 2023, compared to $2.8 million in Q3 2023 and $4.6 million in Q2 2023.